Follow
Cancer genomic profiling
Cancer genomic profiling is a laboratory technique used in the generation of personalized medicine. The genomic profiling evaluates all the genes present in tumor to determine an optimal course of treatment for an individual.
-
OCT 16, 2013 | 1:00 PMC.E. CREDITS
Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...Speaker: Kristin Landis-Piwowar, PhD, MLSOCT 16, 2013 | 9:00 AMC.E. CREDITS
It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...Speaker: Charles M. Perou, PhDAUG 22, 2013 | 5:00 PMC.E. CREDITS
Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...Speaker: Prof. Patrick Tan, MD, PhDPresented at: Genetics and Genomics Virtual Event Series 2013
AUG 21, 2013 | 10:00 AMC.E. CREDITS
Massively parallel sequencing technology has proven to enable the identification of driver genetic alterations in patients' tumors that may be suppressed by targeted therapies. Through retros...
OCT 16, 2013 | 1:00 PM
C.E. CREDITS
Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
Speaker:
Kristin Landis-Piwowar, PhD, MLS
OCT 16, 2013 | 9:00 AM
C.E. CREDITS
It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
Speaker:
Charles M. Perou, PhD
AUG 22, 2013 | 5:00 PM
C.E. CREDITS
Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...
Speaker:
Prof. Patrick Tan, MD, PhD
Presented at: Genetics and Genomics Virtual Event Series 2013
AUG 21, 2013 | 10:00 AM
C.E. CREDITS
Massively parallel sequencing technology has proven to enable the identification of driver genetic alterations in patients' tumors that may be suppressed by targeted therapies. Through retros...